Natixis Advisors
MGNX icon

Natixis Advisors’s MacroGenics MGNX Stock Holding History

Natixis Advisors’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-24,201
Closed -$356K – 1611
2024
Q1 		$356K Sell
24,201
-6,691
-22% -$101K ﹤0.01% 1450
2023
Q4 		$297K Buy
+30,892
New +$214K ﹤0.01% 1469
2022
Q1 		– Sell
-14,600
Closed -$234K – 1453
2021
Q4 		$234K Sell
14,600
-672
-4% -$12.6K ﹤0.01% 1341
2021
Q3 		$320K Sell
15,272
-658
-4% -$15.8K ﹤0.01% 1264
2021
Q2 		$428K Sell
15,930
-339
-2% -$9.93K ﹤0.01% 1231
2021
Q1 		$518K Buy
16,269
+5,809
+56% +$141K ﹤0.01% 1163
2020
Q4 		$239K Buy
+10,460
New +$241K ﹤0.01% 1194

Other funds holding MGNX

BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Natixis Advisors's MGNX Position: Q2 2024 in Review

Natixis Advisors sold out of MacroGenics (MGNX) in Q2 2024, closing a stake of 24,201 shares — an estimated $356K sold.

Natixis Advisors first reported a position in MGNX in Q4 2020 and held it in 7 quarters. The position peaked at $518K in Q1 2021. 146 funds tracked by Wall St. Rank hold MGNX as of Q2 2024.

  • Natixis Advisors reported no remaining MacroGenics position as of Q2 2024 after selling out during the quarter.
  • Natixis Advisors sold 24,201 MacroGenics shares in Q2 2024, an estimated $356K.
  • Natixis Advisors first reported a position in MacroGenics in Q4 2020 and held it in 7 quarters.
  • Natixis Advisors's MacroGenics position peaked at $518K in Q1 2021.
  • 146 funds tracked by Wall St. Rank held MacroGenics as of Q2 2024.

Based on Natixis Advisors's 13F filing for Q2 2024, filed 1 Aug 2024.